danny-i-gohel
Danny I Gohel, PhD
Professor of Biomedical Sciences

Education

DEGREE DEPARTMENT UNIVERSITY YEAR
Ph.D Clinical Biochemistry The University of Hong Kong 1997
M.Phil Clinical Biochemistry Hong Kong Polytechnic, Hong Kong 1989
B.S Clinical Chemistry & Biology University of South Florida 1986

Biography

Prof. Danny Gohel completed his Clinical Chemistry degree in USA and returned to Hong Kong for PhD studiesat the University of Hong Kong. He is currently the Professor of Biomedical Sciences and Associate Vice-President (Academic Development) at the Tung Wah College, Hong Kong.


Research Interest

  • Bladder cancer – pathobiology; Glycosaminoglycans
  • Nano-magnetic particles
  • Rare cell isolation
  • Renal stone disease
  • Heavy metal detection
  • Traditional Chinese medicine – Therapeutic evidences

Scientific Activities

Employment History
2009 -present Professor & Dean, School of Medical & Health Sciences, Tung Wah College, Hong Kong
2005-2012 Associate Dean & Associate Professor, Dept. of Health Technology & Informatics, The Hong Kong Polytechnic University (HKPolyU), Hong Kong.
1993-2005 Assistant Professor, Biomedical Science, HKPolyU, Hong Kong.
Research and Training

Publications

  1. Rodgers AL, Webber D, Ramsout R, Gohel MDI (2015), Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former, Urolithiasis, 43(1):21-27.
  2. Rodgers AL, Webber D, Ramsout R, Gohel MDI (2014),       Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy, Urolithiasis,  42(3):221-225
  3. Ng CF, Hon KLE, Gohel MDI (2013), Effects of melamine on urine crystallization kinetics and cell responses. Hong Kong Med J, 19(6):23-25.
  4. Poon NW, Gohel MDI, Lau C, Hon EKL, Leung PC, Ng CF (2012), Melamine crystallization: the physicochemical properties, interactions with other lithogenic salts and response to therapeutic agents, J Urology, 187(4):1483-1490.
  5. Yuen JWM, Gohel MDI, Poon NW, Shum DKY, Tam PC, Au DWT (2010), The initial and subsequent inflammatory events during calcium oxalate lithiasis, Clin Chim Acta 411:1018-1026.
  6. Rodgers AL, Webber D, Ramsout R, Gohel MDI (2015), Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former, Urolithiasis, 43:21-27.
  7. Yuen JWM,  Gohel MDI*, Ng CF (2011), The differential immunological activities of Ganoderma lucidum on human pre-cancerous uroepithelial cells, J. Ethnopharmacology, 135:711-718.
  8. Gohel MDI, Shum DKY, Tam PC (2007), Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis, Carbohydrate Research, 342:79-86.
  9. Gohel MDI, Wong SP (2006), Chinese herbal medicines and their efficacy in treating renal stones, Urol Res, 34:365-372.
  10. Shum DKY, Gohel MDI, Tam PC (1999), Hyaluronans – crystallization-promoting activity andHPLC analysis of urinary excretion. J Am Soc Nephrol, 10(11) S397-S403
     
Autoimmune Journal Flyer